A carregar...
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
Epidermal growth factor receptor (EGFR) is a validated target in different human malignancies. EGFR tyrosine kinase inhibitors (TKIs) are known to contribute considerably to the extension of progression‐free survival in EGFR‐mutant non‐small cell lung cancer and monoclonal antibodies (mAbs) targetin...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528378/ https://ncbi.nlm.nih.gov/pubmed/22189054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2011.11.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|